Literature DB >> 862246

Specific removal of antibody by extracorporeal circulation over antigen immobilized in collodion-charcoal.

D S Terman, T Tavel, D Petty, M R Racic, G Buffaloe.   

Abstract

Studies were undertaken to determine whether BSA immobilized in collodion membranes adherent to activated charcoal particles, would be capable of specifically removing circulating BSA antibody in vitro and in vivo in an extracorporeal system in dogs. Up to 59-8 mg of BSA were retained in collodion membranes adherent to small particles. In vitro studies demonstrated that immobilized BSA could specifically reduce BSA binding activity from circulating antisera. For in vivo studies, an extracorporeal circulation system was established and arterial blood was circualted through a continuous flow celltrifuge in which plasma was separated from formed elements of the blood. Only plasma was circulated over the BSA collodion-charcoal immunoadsorbent. Anti-BSA and anti-HSA atibodies were passively infused into dogs and, after an equlibration period of 12 or 15 min, plasma was passed over the BSA collodion-charcoal immunoadsorben. Plasma exhibited a sharp reduction in BSA binding over the next 30-60 min with only slight reduction in anti-HSA binding the same period. Dogs, actively immunized to BSA and HSA, were also treated by extracorporeal plasma perfusion over BSA collodion-charcoal. A specific decline in BSA binding of sera, was again observed with minimal changes in HSA binding. A post-perfusion rebound of BSA binding was observed which reached pre-perfusion levels after 6-8 days. A second treatment during the rebound period also resulted in a specific decline in BSA binding with a similar pattern of antibody rebound. There were no significant changes in I-labelled BSA recorded on the charcoal before and after in vivo procedures and no signifcant alterations in haematocrit, serum sodium, potassium, calcium, magnesium or creatinine levels before and after the procedures. These data suggests that antigen-coated charcoal may specifically withdraw circulating antibodies in vivo with minimal release of the entrapped antigen and little alteration in the host's haematological and biochemical status.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 862246      PMCID: PMC1540887     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  A quantitative immunochemical measure of the primary interaction between I BSA and antibody.

Authors:  R S FARR
Journal:  J Infect Dis       Date:  1958 Nov-Dec       Impact factor: 5.226

Review 2.  Immune complex disease in experimental animals and man.

Authors:  C G Cochrane; D Koffler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

3.  Chemical action and pharmacology of methotrexate, azathioprine and cyclophosphamide in man.

Authors:  J R Bertino
Journal:  Arthritis Rheum       Date:  1973 Jan-Feb

4.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

5.  The use of protein-substituted nylon catheters for selective immunoadsorption in vivo.

Authors:  L R Lyle; B M Parker; C W Parker
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

6.  Specific suppression of immune responses.

Authors:  D A Rowley; F W Fitch; F P Stuart; H Köhler; H Cosenza
Journal:  Science       Date:  1973-09-21       Impact factor: 47.728

7.  Rapid plasma exchange with the continuous flow centrifuge.

Authors:  J McCullough; I E Fortuny; B J Kennedy; J R Edson; R F Branda; H S Jacob
Journal:  Transfusion       Date:  1973-03       Impact factor: 3.157

8.  Specific extraction of antigen in vivo by extracorporeal circulation over antibody immobilized in collodion-charcoal.

Authors:  D S Terman; D Petty; D Ogden; C Pefley; G Buffaloe
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

9.  Mechanisms of passive sensitization. I. Presence of IgE and IgG molecules on human leukocytes.

Authors:  K Ishizaka; H Tomioka; T Ishizaka
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

10.  Specific removal of bovine serum albumin (BSA) antibodies in vivo by extracorporeal circulation over BSA immobilized on nylon microcapsules.

Authors:  D S Terman; T Tavel; D Petty; A Tavel; R Harbeck; G Buffaloe; R Carr
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

View more
  4 in total

1.  Plasma exchange and plasmapheresis.

Authors:  N A Buskard
Journal:  Can Med Assoc J       Date:  1978-10-07       Impact factor: 8.262

2.  Specific hemoperfusion through agarose acrobeads.

Authors:  S Margel; L Marcus
Journal:  Appl Biochem Biotechnol       Date:  1986-02       Impact factor: 2.926

3.  Specific suppression of antibody rebound after extracorporeal immunoadsorption. I. Comparison of single versus combination chemotherapeutic agents.

Authors:  D S Terman; R Garcia-Rinaldi; B Dannemann; D Moore; C Crumb; A Tavel; R Poser
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

4.  Suitable hollow fibre immunobioreactors for specific ex vivo removal of antibodies and antigens from plasma.

Authors:  C Larue; V Gueraud; C Rivat
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.